How did CGON's Q4 2024 earnings surprise impact investor sentiment?

CG Oncology's (CGON) Q4 2024 earnings surprise had a positive impact on investor sentiment, as evidenced by the significant percentage change in the stock price. Despite a slight negative EPS surprise, the stock's price increased by 9.36%. This suggests that investors may have reacted favorably to news or events surrounding the earnings report, potentially due to factors such as positive revenue growth, strategic developments, or an improvement in the company's financial outlook.

|code|Ticker|Name|Date|Percentage Change|market_code|
|---|---|---|---|---|---|
|CGON|CGON.O|CG Oncology|20240412|-0.2509|185|
|CGON|CGON.O|CG Oncology|20240415|-5.3082|185|
|CGON|CGON.O|CG Oncology|20240416|-3.1084|185|
|CGON|CGON.O|CG Oncology|20240417|-0.1645|185|
|CGON|CGON.O|CG Oncology|20240418|-2.9937|185|
|CGON|CGON.O|CG Oncology|20240419|0.0566|185|
|CGON|CGON.O|CG Oncology|20240422|-5.0934|185|
|CGON|CGON.O|CG Oncology|20240423|8.2588|185|
|CGON|CGON.O|CG Oncology|20240424|-0.7161|185|
|CGON|CGON.O|CG Oncology|20240425|0.4161|185|